West Pharmaceutical Sets 2024 EPS Guidance at $7.50-$7.75
February 15, 2024 at 06:45 AM EST
WST reported a robust fourth-quarter with net sales of $732.0 million, marking a 3.3% increase.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |